Kymera Therapeutics Inc - KYMR - stock price prediction, stock price target, analyst ratings from 20 analysts

Kymera Therapeutics Inc has a share price target of US$ 60, revenue growth forecast of 75.2%, and profit growth estimate of -25.2% for FY25, based on top 20 analyst calls.